Husisian Quoted on Effect of CFIUS Investment Reciprocity on Chinese Deals
14 March 2017
Partner Gregory Husisian was quoted in a Law 360 article, “Reciprocity in CFIUS Reviews Might Hit Chinese Deals Hardest,” covering Trump’s standpoint on the sale of the Chicago Stock Exchange to a Chinese investment group, as it relates to reciprocity through the Committee on Foreign Investment in the United States (CFIUS).
Husisian said that Trump viewed the sale as “problematic” and that it “is in his view taking advantage of the free trade rules.” He continued by explaining that Trump “is clearly skeptical of trade and investment from China, and China is really the largest source of CFIUS filings, and that’s a trend that’s not going to go away.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”